In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 698-699

  Izumikawa, Koichi ^a   Hirakata, Yoichi ^a   Yamaguchi, Toshiyuki ^a   Yoshida, Ryoji ^a   Tanaka, Hironori ^a   Takemura, Hiromu ^b   Maesaki, Shigefumi ^a   Tomono, Kazunori ^a   Kaku, Mitsuo ^b   Izumikawa, Kin Ichi ^c   Kamihira, Shimeru ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Izumikawa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; MACROLIDE; MINOCYCLINE; OFLOXACIN; QUINOLONE DERIVATIVE; RPR 106972; SPARFLOXACIN; STREPTOGRAMIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031895281     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.698     Document Type: Article

References (14)

1. Andrews, J. M., and R. Wise. 1994. The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens. J. Antimicrob. Chemother. 33:849-853.
2. Barry, A. L., and P. C. Fuchs. 1995. In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens. Antimicrob. Agents Chemother. 39:238-240.
3. Bryson, H. M., and C. M. Spencer. 1996. Quinupristin-dalfopristin. Drugs 52:406-415.
4. Chanock, R. M., L. Hayflick, and M. F. Barile. 1962. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as PPLO. Proc. Natl. Acad. Sci. USA 48:41-49.
5. Ishida, K., M. Kaku, K. Irifune, R. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, N. Suyama, K. Tomono, H. Koga, S. Kohno, K. Izumikawa, and K. Kara. 1994. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 38:790-798.
6. Kaku, M., K. Ishida, K. Irifune, R. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, K. Tomono, N. Suyama, H. Koga, S. Kohno, and K. Hara. 1994. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 38:738-741.
7. Lucier, T. S., K. Heitzman, S.-K. Liu, and P.-C. Hu. 1995. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 39:2770-2773.
8. Osada, Y., and H. Ogawa. 1983. Antimycoplasmal activity of ofloxacin (DL-8280). Antimicrob. Agents Chemother. 23:509-511.
9. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:2071-2074.
10. Pechere, J. C. 1996. Streptogramins. A unique class of antibiotics. Drugs 51(Suppl. 1):13-19.
11. Petitpretz, P., J. C. Guerin, G. Nouvet, R. Poirier, F. Portier, J. Vergeret, P. Fraysse, and J. B. Vercken. 1994. Treatment of community-acquired pneumonia by pristinamycin (Pyostacine 500). Results of a non comparative open study. Rev. Pneumol. Clin. 50:63-67.
12. Vannuffel, P., and C. Cocito. 1996. Mechanism of action of streptogramins and macrolides. Drugs 51(Suppl. 1):20-30.
13. Waites, K. B., G. H. Cassell, K. C. Canupp, and P. B. Fernandes. 1988. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob. Agents Chemother. 32:1500-1502.
14. Waites, K. B., L. B. Duffy, T. Schmid, D. Crabb, M. S. Pate, and G. H. Cassell. 1991. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob. Agents Chemother. 35:1181-1185.